Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study by Chua, Joel V., Ntem‐Mensah, Afua, Abutaleb, Ameer, Husson, Jennifer, Mutumbi, Lydiah, Lam, Ka Wing, Ghosh, Alip, Romani, Sara, Poonia, Bhawna, Lee, Sam, Luz Pascual, M., Frumkin, Lyn R., Kottilil, Shyamsundaran

Get full text

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial by Chua, Joel V., Davis, Charles, Husson, Jennifer S., Nelson, Amy, Prado, Ilia, Flinko, Robin, Lam, Ka Wing J., Mutumbi, Lydiah, Mayer, Bryan T., Dong, Dan, Fulp, William, Mahoney, Celia, Gerber, Monica, Gottardo, Raphael, Gilliam, Bruce L., Greene, Kelli, Gao, Hongmei, Yates, Nicole, Ferrari, Guido, Tomaras, Georgia, Montefiori, David, Schwartz, Jennifer A., Fouts, Timothy, DeVico, Anthony L., Lewis, George K., Gallo, Robert C., Sajadi, Mohammad M.

Get full text

2838. Safety and Immunogenicity of a gp120-CD4 Chimeric Subunit Vaccine: A Phase 1a Randomized Controlled Trial by Chua, Joel V, Davis, Charles, Nelson, Amy, Lam, Ka Wing J, Mutumbi, Lydiah, Stafford, Kristen A, Gilliam, Bruce, DeVico, Anthony L, Lewis, George K, Sajadi, Mohammad M

Get full text